Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review - 24/11/17
, M.R. Emamhadi b, S. Yousefzadeh-Chabok a, S.K. Shakouri c, P.F. Høilund-Carlsen d, M.S. Vafaee d, e, f, g, h, 1, T.M. Michel e, f, g, h, 1Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Background |
Selective serotonin reuptake inhibitors (SSRIs) are the most common antidepressants used to preclude maternal pregnancy depression. There is a growing body of literature assessing the association of prenatal exposure to SSRIs with autism spectrum disorder (ASD). The present systematic review and meta-analysis reviewed the medical literature and pooled the results of the association of prenatal exposure to SSRIs with ASD.
Methods |
Published investigations in English by June 2016 with keywords of selective serotonin reuptake inhibitors, SSRI, autism spectrum disorder, ASD, pregnancy, childhood, children, neurodevelopment were identified using databases PubMed and PMC, MEDLINE, EMBASE, SCOPUS, and Google Scholar. Cochran's Q statistic-value (Q), degree of freedom (df), and I2 indices (variation in odds ratio [OR] attributable to heterogeneity) were calculated to analyze the risk of heterogeneity of the within- and between-study variability. Pooled odds ratio (OR) and 95% confidence interval (CI) were reported by a Mantel–Haenszel test.
Results |
There was a non-significant heterogeneity for the included studies ([Q=3.61, df=6, P=0.730], I2=0%). The pooled results showed a significant association between prenatal SSRI exposure and ASD (OR=1.82, 95% CI=1.59–2.10, Z=8.49, P=0.00).
Conclusion |
The evidence from the present study suggests that prenatal exposure to SSRIs is associated with a higher risk of ASD.
Le texte complet de cet article est disponible en PDF.Keywords : Selective serotonin reuptake inhibitors, SSRI, Autism spectrum disorder, ASD, Pregnancy, Childhood
Plan
Vol 45
P. 161-166 - septembre 2017 Retour au numéro
Article précédent
- Self-assessed remission rates after electroconvulsive therapy of depressive disorders
- O. Brus, Y. Cao, E. Gustafsson, M. Hultén, M. Landen, J. Lundberg, P. Nordanskog, A. Nordenskjöld
- Is sensitivity to daily stress predictive of onset or persistence of psychopathology?
- T. Vaessen, M. van Nierop, J. Decoster, P. Delespaul, C. Derom, M. de Hert, N. Jacobs, C. Menne-Lothmann, B. Rutten, E. Thiery, J. van Os, R. van Winkel, M. Wichers, I. Myin-Germeys
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?